Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer

The prognosis of patients with advanced gastric cancer (GC) remains poor despite the recent advances in molecular targeted therapies, and the search for biomarkers that can predict prognosis and additional new agents with acceptable toxicity profiles are needed. Lipolysis-stimulated lipoprotein rece...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncotarget
Главные авторы: Sugase, Takahito, Takahashi, Tsuyoshi, Serada, Satoshi, Fujimoto, Minoru, Ohkawara, Tomoharu, Hiramatsu, Kosuke, Koh, Masahiro, Saito, Yurina, Tanaka, Koji, Miyazaki, Yasuhiro, Makino, Tomoki, Kurokawa, Yukinori, Yamasaki, Makoto, Nakajima, Kiyokazu, Hanazaki, Kazuhiro, Mori, Masaki, Doki, Yuichiro, Naka, Tetsuji
Формат: Artigo
Язык:Inglês
Опубликовано: Impact Journals LLC 2018
Предметы:
Research Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6152476/
https://ncbi.nlm.nih.gov/pubmed/30250639
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25952
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы